Publications

publication banner

2018

Personalized Proteomics for Precision Health: Identifying Biomarkers of Vitreoretinal Disease.   |   G. Velez; P.H. Tang; T. Cabral; G.Y. Cho; D.A. Machlab; S.H. Tsang; A.G. Bassuk; V.B. Mahajan   |   Details
Rates of Bone Spicule Pigment Appearance in patients with Retinitis Pigmentosa Sine Pigmento.   |   V.K.L. Takahashi; J.T. Takiuti; R. Jauregui; V.B. Mahajan; S.H. Tsang   |   Details
Translation of CRISPR Genome Surgery to the Bedside for Retinal Diseases.   |   C.L. Xu; G.Y. Cho; J.D. Sengillo; K.S. Park; V.B. Mahajan; S.H. Tsang   |   Details
PROGRESSION OF SCOTOPIC SINGLE-FLASH ELECTRORETINOGRAPHY IN THE STAGES OF CAPN5 VITREORETINOPATHY.   |   P.H. Tang; T.R. Kinnick; J.C. Folk; M. Mahajan; A.G. Bassuk; S.H. Tsang; V.B. Mahajan   |   Details
Fibrin Glue and Internal Limiting Membrane Abrasion for Optic Disc Pit Maculopathy.   |   D.R.P. Almeida; E.K. Chin; P. Arjmand; G. Velez; L.P. Evans; V.B. Mahajan   |   Details
Autologous stem cell therapy for inherited and acquired retinal disease   |     |   Details

2017

Correction: Recessive coding and regulatory mutations in FBLIM1 underlie the pathogenesis of chronic recurrent multifocal osteomyelitis (CRMO)   |     |   Details
CRISPR-Mediated Ophthalmic Genome Surgery   |   G.Y. Cho; Y. Abdulla; J.D. Sengillo; S. Justus; K.A. Schaefer; A.G. Bassuk; S.H. Tsang; V.B. Mahajan   |   Details

Genome Surgery and Gene Therapy in Retinal Disorders.   |   L. Chan; V.B. Mahajan; S.H. Tsang   |   Details
Diagnostic and Therapeutic Challenges.   |   P. Mishra; V. Kanaujia; K. Sharma; V.B. Mahajan; E.K. Chin   |   Details
Acanthamoeba Endophthalmitis After Recurrent Keratitis And Nodular Scleritis   |   Z. Mammo; D.R.P. Almeida; M.A. Cunningham; E.K. Chin; V.B. Mahajan   |   Details
Limbal Trocar-Cannulas for Complex Vitrectomy Surgery.   |   K.A. Mears; V.B. Mahajan   |   Details
CRISPR-Cas Genome Surgery in Ophthalmology   |   J.E. DiCarlo; J.D. Sengillo; S. Justus; T. Cabral; S.H. Tsang; V.B. Mahajan   |   Details
Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial.   |   S. Russell; J. Bennett; J.A. Wellman; D.C. Chung; Z.F. Yu; A. Tillman; J. Wittes; J. Pappas; O. Elci; S. McCague; D. Cross; K.A. Marshall; J. Walshire; T.L. Kehoe; H. Reichert; M. Davis; L. Raffini; L.A. George; P. Hudson; L. Dingfield; X. Zhu; J.A. Haller; E.H. Sohn; V.B. Mahajan; W. Pfeifer; M. Weckmann; C. Johnson; D. Gewaily; A. Drack; E. Stone; K. Wachtel; F. Simonelli; B.P. Leroy; F. Wright; K.A. High; A.M. Maguire   |   Details
Personalized proteomics in proliferative vitreoretinopathy implicate hematopoietic cell recruitment and mTOR as a therapeutic target   |   N. Roybal; G. Velez; M.A. Toral; S.H. Tsang; A.G. Bassuk; V.B. Mahajan   |   Details
Recessive coding and regulatory mutations in FBLIM1 underlie the pathogenesis of chronic recurrent multifocal osteomyelitis (CRMO).   |   A.J. Cox; B.W. Darbro; R.M. Laxer; G. Velez; X. Bing; A.L. Finer; A. Erives; V.B. Mahajan; A.G. Bassuk; P.J. Ferguson   |   Details
Gene Therapy Restores Mfrp and Corrects Axial Eye Length   |   G. Velez; S.H. Tsang; Y.T. Tsai; C.W. Hsu; A. Gore; A.H. Abdelhakim; M. Mahajan; R.H. Silverman; J.R. Sparrow; A.G. Bassuk;   |   Details
Ocular hypertension after intravitreal dexamethasone (Ozurdex) sustained-release implant   |   E.K. Chin; D.R.P. Almeida; G. Velez; K. Xu; M. Peraire; M. Corbella; Y.M. Elshatory; Y.H. Kwon; K.M. Gehrs; C. Boldt;   |   Details
Dissection of Human Retina and RPE-Choroid for Proteomic Analysis.   |   T. Cabral; M.A. Toral; G. Velez; J.E. DiCarlo; A.M. Gore; M. Mahajan; S.H. Tsang; A.G. Bassuk; V.B. Mahajan   |   Details
Therapeutic drug repositioning using personalized proteomics of liquid biopsies   |   G. Velez; A.G. Bassuk; D. Colgan; S.H. Tsang; V.B. Mahajan   |   Details

Pages